2024-08-09T08:33:48-04:00 2023-12-31 382706146 YEO & YEO PC 1450 EISENHOWER PLACE ANN ARBOR MI 481083283 990 2023-01-01 382117115 EVERSIGHT EVER 8002477250 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108 DIANE HOLLINGSWORTH PRESIDENT & CEO 8002477250 2024-08-07 true true BRIAN R DIXON P01321580 7347691331 2024-08-08 2023 2024-08-08 14:25:15Z DIANE HOLLINGSWORTH 3985 RESEARCH PARK DR ANN ARBOR MI 48108 30775308 false X WWW.EVERSIGHTVISION.ORG X 1986 MI EVERSIGHT IS A 501(C)3 NONPROFIT ORGANIZATION WITH THE MISSION TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. THE EVERSIGHT NETWORK IS RESPONSIBLE FOR RECOVERING, EVALUATING AND PROVIDING HUMAN EYE TISSUE FOR TRANSPLANTATION; ADVANCING RESEARCH INTO THE CAUSES AND CURES OF BLINDING EYE CONDITIONS; PROMOTING DONATION AWARENESS THROUGH PUBLIC AND PROFESSIONAL EDUCATION; AND PROVIDING HUMANITARIAN AID TO PEOPLE AROUND THE WORLD IN NEED OF CORNEAL TRANSPLANTATION. FOUNDED IN 1947, EVERSIGHT MAINTAINS ITS COMMITMENT TO EXCELLENCE AS AN ACCREDITED MEMBER OF THE EYE BANK ASSOCIATION OF AMERICA (EBAA) AND BY MEETING THE HIGHEST QUALITY STANDARDS SET BY THE U.S. FOOD AND DRUG ADMINISTRATION. THE NONPROFIT OPERATES 24/7/365 IN CONNECTICUT, ILLINOIS, MICHIGAN, NEW JERSEY, OHIO AND SOUTH KOREA, AND COLLABORATES WITH SURGEONS, RESEARCHERS, ACADEMIC MEDICAL CENTERS AND EYE BANKS ACROSS THE UNITED STATES AND ABROAD. EVERSIGHT WORKS WITH THE 14 14 191 104 0 864304 1283375 24444041 27810618 134853 1529170 44903 39192 25488101 30662355 0 0 12646438 13586009 0 730888 11369600 13940924 24016038 27526933 1472063 3135422 41527985 45849022 22776198 23048867 18751787 22800155 X EVERSIGHT'S MISSION IS TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. BLINDING EYE DISEASES AFFECT 80 MILLION AMERICANS. THAT MEANS MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, DRIVE TO WORK OR READ THE NEWSPAPER ON A SUNDAY MORNING. THEIR VISION LOSS RESULTS IN AN ECONOMIC IMPACT OF 51.4 BILLION EVERY YEAR IN THE UNITED STATES ALONE. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL MOTHERS CAN SEE THEIR CHILDREN AND ALL CHILDREN CAN GROW UP TO LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. TO MAKE VISION A REALITY FOR ALL, EVERSIGHT CONTINUOUSLY WORKS TO EXPAND ITS REACH, CONNECT MORE EFFECTIVELY WITH COMMUNITIES IN NEED AND PROVIDE THE GIFT OF SIGHT TO EVERYONE. false false 21274312 27810618 RESORING SIGHT EVERSIGHT CONTINUES TO TAKE MEANINGFUL STEPS TOWARD TRANSFORMING THE FUTURE OF VISION CARE BY SUPPORTING SUSTAINABLE EYE BANKING INFRASTRUCTURE AND PROVIDING PRICELESS CLINICAL EDUCATION. IN 2023, EVERSIGHT PROVIDED THE GIFT OF SIGHT TO MORE THAN 9,200 PEOPLE ACROSS THE UNITED STATES AND AROUND THE WORLD. EVERSIGHT PROVIDED 42 CORNEAS FOR SIGHT-RESTORING TRANSPLANTS GRATIS OR AT A REDUCED FEE FOR UNINSURED PATIENTS. EVERSIGHT'S WORK BEGAN IN 1947 WITH THE ESTABLISHMENT OF THE FOURTH EYE BANK IN THE UNITED STATES, THEN KNOWN AS THE ILLINOIS EYE-BANK. OVER TIME, NONPROFIT EYE BANKS WERE ESTABLISHED IN EVERY STATE TO MEET THE CRITICAL DEMAND FOR CORNEAL TISSUE TO TREAT PREVENTABLE BLINDNESS. IN 1985, THE ILLINOIS EYE-BANK AND MICHIGAN EYE-BANK FORMED A PARTNERSHIP ONE THAT WOULD EARN A REPUTATION FOR CLINICAL EXCELLENCE MADE POSSIBLE BY SOME OF THE FINEST MEDICAL DIRECTORS, STAFF AND BOARD MEMBERS IN THE EYE BANKING FIELD. THE SUCCESS OF THE ORGANIZATION ATTRACTED AFFILIATIONS WITH OTHER REGIONAL EYE BANKS FORMING ONE OF THE LARGEST NETWORKS OF EYE BANKS IN THE U.S. IN 2015, THE NETWORK BECAME KNOWN AS EVERSIGHT, ALL WORKING TOGETHER AS A UNIFIED OPERATION TO DELIVER THE HIGHEST QUALITY SERVICES TO SURGEONS AND THEIR PATIENTS AND TO CONTINUE TO GROW OUR IMPACT AROUND THE WORLD. EVERSIGHT PROVIDED MORE THAN 13,800 TISSUES FOR TRANSPLANTATION, RESEARCH AND EDUCATION GLOBALLY IN 2023. WE WORKED OR PLACED TISSUE WITH PHYSICIANS AND RESEARCHERS IN 33 COUNTRIES AND FACILITATED TRAINING FOR 865 CLINICIANS. TOGETHER WITH ALL OUR PARTNERS-ADVOCATES, DONOR FAMILIES, TRANSPLANT RECIPIENTS, SURGEONS, LIONS, FELLOW EYE BANKS, HEALTHCARE LEADERS, PHILANTHROPIC SUPPORTERS AND MANY OTHERS-WE WERE ABLE TO MAKE VISION A REALITY FOR MORE PEOPLE WORLDWIDE. 141201 FINDING A CURE IN THE PURSUIT OF ELIMINATING BLINDING EYE DISEASES, EVERSIGHT ESTABLISHED THE EVERSIGHT CENTER FOR VISION AND EYE BANKING RESEARCH IN CLEVELAND, OHIO, TO PROVIDE LEADING OPHTHALMOLOGY RESEARCHERS WITH THE RESOURCES THEY NEED TO FIND CURES AND TREATMENTS FOR EYE DISEASES SUCH AS AGE-RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY AND GLAUCOMA. EVERSIGHT PROVIDED MORE THAN 4,500 TISSUES FOR RESEARCH AND EDUCATION PURPOSES IN 2023. OUR IN-HOUSE RESEARCH TEAM ALSO PROVIDED EVERSIGHT PARTNERS WITH VALUABLE RESEARCH AND DEVELOPMENT SERVICES, AND PIONEERED NEW EYE BANKING PRACTICES. SINCE 2014, THE EVERSIGHT RESEARCHERS HAVE AUTHORED 47 PUBLICATIONS AND GIVEN 15+ PRESENTATIONS AT INTERNATIONAL CONFERENCES, AND SUPPORTED 230+ PUBLICATIONS OF OUR COLLABORATORS. THE TEAM PUBLISHED EIGHT PEER-REVIEWED PAPERS IN 2023, COVERING TOPICS INCLUDING: BIOLOGIC THERAPEUTICS AND REGENERATIVE MEDICINE; CORNEAL EPITHELIAL HEALING AND STEM CELLS; WET LAB METHODS FOR DMEK SURGICAL TRAINING; RETINAL HISTOLOGY IN RARE GENETIC DISEASE; LITERATURE REVIEW OF CHILDHOOD VISION LOSS; IMPACT OF COVID-19 ON EYE BANKING; DSAEK CELL LOSS IN PRELOADED DEVICES; AND MORE. WITH OUR MANY ACADEMIC PARTNERS, EVERSIGHT RESEARCHERS HAVE CONTRIBUTED TO A TOTAL OF 316 PEER-REVIEWED SCIENTIFIC PAPERS THAT HAVE GARNERED 6,000 CITATIONS AND COUNTING. EVERSIGHT HAS A LONGSTANDING TRACK RECORD OF RESEARCH AND DEVELOPMENT, HAVING AWARDING MORE THAN 4 MILLION IN GRANTS TO DATE THAT STIMULATE PIONEERING CLINICAL AND BASIC SCIENCE RESEARCH AIMING TO DEVELOP NEW WAYS TO RESTORE SIGHT, PREVENT BLINDNESS AND ULTIMATELY HELP PATIENTS LIVE LIFE TO THE FULLEST. SINCE 1980, OUR EYE & VISION RESEARCH GRANT PROGRAM HAS SUPPORTED RESEARCHERS AT LEADING ACADEMIC MEDICAL INSTITUTIONS INCLUDING HARVARD, TUFTS, CLEVELAND CLINIC, CASE WESTERN RESERVE, UNIVERSITY OF MICHIGAN, NORTHWESTERN AND MORE. BY DESIGN, EVERSIGHT'S GRANT PROGRAM PROVIDES CRITICAL, EARLY-STAGE FUNDING THAT IS INTENDED TO DRIVE FOUNDATIONAL RESEARCH AND DISCOVERY. MANY OF THESE PROJECTS HAVE STIMULATED LARGER-SCALE STUDIES AND WON FURTHER FINANCIAL SUPPORT FROM THE NATIONAL INSTITUTES OF HEALTH. IN THE 2024 FUNDING CYCLE, EVERSIGHT AWARDED FOUR GRANTS AT TUFTS UNIVERSITY, WAYNE STATE UNIVERSITY AND UNIVERSITY OF MICHIGAN TO ADVANCE STUDIES TO INVESTIGATE THE EFFICIENCY OF LOCAL ADOPTIVE TRANSFER OF PLASMACYTOID DENDRITIC CELLS (PDCS) IN IMPROVING CORNEA GRAFT SURVIVAL IN HIGH-RISK TRANSPLANTATION; DUAL-ACTING NANOFORMULATIONS FOR THE TREATMENT OF OCULAR BACTERIAL INFECTIONS; PATHOETIOLOGY OF EXTRACELLULAR RETINAL DEPOSITS THAT CAUSE IRREVERSIBLE BLINDNESS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION (AMD) BY DEFINING THE MECHANISM AND COMPOSITION OF RETINAL PIGMENT EPITHELIAL (RPE) LIPOPROTEIN SECRETION; AND OPTIMAL VECTORS AND METHODS FOR DELIVERING GENE BASE EDITING REAGENTS TO TREAT CORNEAL DYSTROPHIES CAUSED BY TGFBI GENE MUTATIONS. EACH YEAR, RECIPIENTS ARE SELECTED BY AN INDEPENDENT REVIEW PANEL OF ACADEMIC RESEARCHERS AND OPHTHALMOLOGISTS. THIS DISTINGUISHED PANEL AWARDS PROPOSALS THAT ENCOURAGE MEANINGFUL SCIENTIFIC INQUISITION AND ALIGN WITH EVERSIGHT'S MISSION TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. 1122891 SUSTAINABLE INTERNATIONAL IMPACT EVERSIGHT WORKS TO ELIMINATE CORNEAL BLINDNESS WORLDWIDE THROUGH EYE BANK DEVELOPMENT, CLINICAL TRAINING AND TISSUE PROVISION. WITH MORE THAN 75 YEARS OF EYE BANKING EXPERTISE, WE DELIVER BOTH SHORT- AND LONG-TERM SOLUTIONS TO TRANSFORM THE LIVES OF MORE THAN 12 MILLION PEOPLE SUFFERING FROM CORNEAL BLINDNESS GLOBALLY. IN 2023, EVERSIGHT INTERNATIONAL PROVIDED MORE THAN 3,800 TISSUES FOR TRANSPLANT AND WORKED WITH SURGEONS IN 32 COUNTRIES OUTSIDE THE UNITED STATES, MAKING THE GIFT OF SIGHT POSSIBLE FOR MANY IN NEED. EVERSIGHT PROVIDED 99 CORNEA TISSUES FOR SIGHT-RESTORING TRANSPLANTS GRATIS OR AT A REDUCED RATE FOR MEDICAL MISSIONS AND UNINSURED PATIENTS OUTSIDE THE UNITED STATES. IN MEDICALLY UNDERSERVED AREAS, EVERSIGHT GLOBAL DEVELOPMENT FOSTERS AUTHENTIC RELATIONSHIPS WITH LOCAL LEADERS TO ESTABLISH CULTURALLY INFORMED EYE DONATION FRAMEWORKS AND SUSTAINABLE EYE BANKING INFRASTRUCTURE. OUR EXPERIENCED TEAM OFFERS VITAL CLINICAL TRAINING AND EDUCATION TO EYE SURGEONS AND EYE BANK TECHNICIANS ON THE LATEST CLINICAL METHODS, IMPROVING ACCESS TO LIFE-CHANGING TRANSPLANTS. THROUGH THE INCREDIBLE GENEROSITY OF OUR DONORS AND DONOR FAMILIES, EVERSIGHT GLOBAL DEVELOPMENT ALSO PROVIDES CORNEAL TISSUE FROM THE UNITED STATES FOR TRANSPLANT AND RESEARCH GLOBALLY, PROVIDING HOPE FOR THE FUTURE AND RESTORING SIGHT TO PATIENTS IN NEED. OUR GLOBAL MISSION IS INFORMED BY AND ALIGNS WITH THE UNITED NATIONS SUSTAINABLE DEVELOPMENT GOALS (SDGS), WITH PARTICULAR ATTENTION GIVEN TO: 3 GOOD HEALTH AND WELL-BEING, 4 QUALITY EDUCATION, 8 DECENT WORK AND ECONOMIC GROWTH, 10 REDUCED INEQUALITIES AND 11 SUSTAINABLE CITIES & COMMUNITIES. ACCORDING TO THE WORLD HEALTH ORGANIZATION, EVERY DOLLAR SPENT ON IMPROVING EYE HEALTH IN UNDERDEVELOPED AREAS GENERATES A FOUR-FOLD RETURN ON INVESTMENT. TO ADDRESS SYSTEMIC UNMET NEED, EVERSIGHT ACTIVELY WORKS WITH MEDICAL PROFESSIONALS, GOVERNMENTS, VISION HEALTH ORGANIZATIONS AND OTHER NGOS IN REGIONS LACKING EYE BANKS AND INFRASTRUCTURE, INCLUDING UNITED ARAB EMIRATES, PAKISTAN AND SOUTH KOREA. WITH PROVEN EYE BANKING AND TECHNICAL TRAINING PRACTICES-AND HAVING PLAYED A PART IN THE ELIMINATION OF THE U.S. CORNEA TRANSPLANT WAITING LIST-EVERSIGHT IS UNIQUELY QUALIFIED TO WORK WITH COUNTRIES LACKING TRANSPLANT PROGRAMS TO HELP THEM ESTABLISH NATIONAL NETWORKS FOR EYE BANKING AND CORNEA DONATION WITH CULTURALLY APPROPRIATE DONATION MODELS AND STATE-OF-THE-ART CLINICAL CAPABILITIES. GLOBALLY, AN ESTIMATED 2.2 BILLION PEOPLE ARE IMPACTED BY BLINDNESS AND VISUAL IMPAIRMENT. NINETY PERCENT OF VISION-IMPAIRED PEOPLE LIVE IN LOW- AND MIDDLE- INCOME COUNTRIES. APPROXIMATELY ONE BILLION OF THESE INDIVIDUALS ARE COPING WITH BLINDNESS OR VISUAL IMPAIRMENT THAT CAN BE CHARACTERIZED AS PREVENTABLE OR NOT SUFFICIENTLY ADDRESSED. VISION LOSS RESULTS IN SUBSTANTIAL ECONOMIC IMPACT WORLDWIDE DUE TO THE INABILITY OF PEOPLE WHO ARE VISION IMPAIRED TO CONTRIBUTE TO THEIR FULLEST IN THEIR COMMUNITIES. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL PEOPLE IN EVERY COMMUNITY CAN LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. WHILE PROVIDING FOR IMMEDIATE GLOBAL CORNEA TRANSPLANT NEEDS WITH U.S. DONOR TISSUE, EVERSIGHT CONTINUES TO ADDRESS THE GLOBAL BURDEN BY EMPOWERING INTERNATIONAL COMMUNITIES TO TAKE MEANINGFUL, SUSTAINABLE STEPS EVERY DAY TO MAKE VISION A REALITY FOR ALL. 22538404 true true false false false false false false false true true false false true true false false true false false false false false false true false false false false true false false false false false false false false false false false false false true true true false false true 28 0 191 true false false false false false true true false false false false false false X 14 14 false false false false false false false true true false false true true true true true true true true false MI IL X JULIE COLLINS 7347802119 3985 RESEARCH PARK DR ANN ARBOR MI 48108 MICHAEL O'KEEFE COO 50.00 X 219990 0 59407 JULIE COLLINS CFO 50.00 7.50 X 224333 0 59953 MICHAEL TITUS VP CLINICAL 50.00 X 178075 0 60169 DIANE HOLLINGSWORTH PRESIDENT & 50.00 X 264097 0 68580 BRET HOPMAN VP MARKETING 50.00 X 153446 0 51732 PATTY JO HERNDON CHAIR 1.00 X X 0 0 0 KATHY L ZELENOCK VICE CHAIR 1.00 X X 0 0 0 DANIELLE E D'ARCY TREASURER 1.00 X X 0 0 0 MAHMOUD N GHAZZI MD PHD SECRETARY 1.00 X X 0 0 0 JAROLD ANDERSON IMM. PAST CH 1.00 X 0 0 0 LORENZO CERVANTES MD DIRECTOR 1.00 X 0 0 0 JONATHAN LASS MD DIRECTOR 1.00 X 0 0 0 SHAHZAD MIAN MD DIRECTOR 1.00 X 0 0 0 CAROL CUNNINGHAM MD DIRECTOR 1.00 X 0 0 0 SANDRA FLETCHER DIRECTOR 1.00 X 0 0 0 PROBI KAPUR DIRECTOR 1.00 X 0 0 0 JOSEPH RADTKA DIRECTOR 1.00 X 0 0 0 CAROLYN M WELSH DIRECTOR 1.00 X 0 0 0 PETER WROBLEWSKI DIRECTOR 1.00 X 0 0 0 CATHERINE MCCLORY DIR. COMPLIA 50.00 X 146074 0 31631 INDU VADAKKEPATTATH DATA SCI. & 50.00 X 142932 0 31526 ONKAR SAWANT DIR. RESEARC 50.00 X 158673 0 31465 KARA KELLY DIR. PARTN. 50.00 X 106022 0 23602 CAITLIN LOPES DIR. PARTN. 50.00 X 111233 0 46323 1704875 464388 10 false true false MIDNITE AIR CORP MNX 5000 AIRPORT PLAZA DRIVE SUITE 100 LONG BEACH CA 90815 SHIPPING 1212191 BAUSCH & LOMB SURGICAL 3365 TREE COURT INDUSTRIAL BLVD ST LOUIS MO 63122 MEDICAL TECH. 935564 MCKESSON MEDICAL-SURGICAL INC 6555 STATE HWY 161 IRVING TX 75039 MEDICAL DISTRIB 935034 MORIA INC 1050 CROSS KEYS DRIVE DOYLESTOWN PA 18902 MEDICAL INSTRUM 674303 EUROFINS DONOR & PRODUCT TESTING INC 6933 S REVERE PKWY CENTENNIAL CO 80112 MEDICAL LAB 643050 5 147666 1135709 20182 1283375 EYE TISSUE FEES 621500 25393795 25393795 INTERCOMPANY CHARGES 621500 2257961 2257961 OTHER REVENUE 621500 158862 158862 27810618 643775 643775 885397 2 885397 -2 885395 885395 152143 147666 112951 39192 39192 30662355 27810618 1568362 1339782 279397 1060385 9330876 7353634 1599183 378059 293770 250923 29642 13205 1785028 1426748 284773 73507 836553 610920 195137 30496 8556 4711 3845 44600 24556 20044 429174 236293 192881 14584 14584 226883 183856 31154 11873 282629 231534 41162 9933 1353756 1101849 202422 49485 191395 141475 46915 3005 160223 52819 93636 13768 232903 189562 34827 8514 374484 310976 51463 12045 CLINICAL LAB & TECH EXP 9753141 9753141 MISCELLANEOUS 259508 5468 254971 -931 MEMBERSHIP DUES 178018 178018 BUSINESS DEVELOPMENT 167832 82747 82143 2942 263238 119777 18474 124987 27526933 22538404 4257641 730888 2483366 3479320 5263160 4246975 2930442 3851794 157170 148372 16043671 7433536 8105268 8610135 9147484 12720929 -1338359 13441095 14129856 41527985 45849022 1901749 2109308 400 400 7059250 6510250 13814799 14428909 22776198 23048867 X 18606591 22568195 145196 231960 18751787 22800155 41527985 45849022 X 3135422 1109800 -83904 -112950 X false true X true false X 1197972 672370 3627186 864304 1283375 7645207 21313494 19849742 23990620 24444041 27810618 117408515 22511466 20522112 27617806 25308345 29093993 125053722 3750 400130 403880 8766065 3989386 6290645 6665837 25711933 8769815 4389516 6290645 6665837 26115813 98937909 246808 142247 156491 181255 643775 1370576 246808 142247 156491 181255 643775 1370576 20345 659 43903 38192 103099 22758274 20684704 27774956 25533503 29775960 126527397 0.78190 0.82830 0.01000 0.01000 X PART III, LINE 12 MISCELLANEOUS 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 179087 179087 179087 179087 179087 179087 179087 179087 179087 179087 0.49000 0.51000 false false 7408082 1304648 6103434 1285068 1285068 1503454 6128888 -4625434 5723775 5723775 8486843 RECEIVABLE FROM RELATED ENTITY 14032788 DEPOSIT 97068 14129856 PAYABLE TO RELATED ENTITY 13916858 CAPITAL LEASE OBLIGATION 512051 14428909 30662355 30662355 30662355 27639883 112950 112950 27526933 27526933 SCHEDULE D, PAGE 2, PART V, LINE 4 THE PURPOSE OF THE GIFT OF HOPE EYE AND VISION RESEARCH ENDOWMENT FUND IS TO PROVIDE FOR ANNUAL DISTRIBUTIONS TO SUPPORT EVERSIGHT'S GIFT OF HOPE EYE AND VISIONS RESEARCH PROGRAM. THE PURPOSE OF THE GIFT OF SIGHT CHARITABLE ENDOWMENT FUND IS TO PROVIDE FOR ANNUAL DISTRIBUTIONS TO SUPPORT EVERSIGHT'S PROGRAM WHICH WAIVES TISSUE PROCESSING FEES, OR REDUCES THE FEE FOR PATIENTS WHO ARE UNABLE TO PAY THE FULL AMOUNT. THE PURPOSE OF THE COMMUNITY EDUCATION ENDOWMENT FUND IS TO PROVIDE FOR ANNUAL DISTRIBUTIONS TO SUPPORT EVERSIGHT'S COMMUNITY EDUCATION PROGRAM. SCHEDULE D, PAGE 4, PART XII, LINE 2D SPECIAL EVENTS EXPENSES 112,950 GIFT OF SIGHT M 230818 107739 123079 49822 7694 31360 NIGHT FOR SIGHT 41543 19229 22314 19517 1 27448 20698 6750 240 1052 3266 299809 147666 152143 240 50874 7694 54143 112951 39192 X X X false false false false false false false false false MICHAEL O'KEEFE COO 219990 13603 45804 279397 JULIE COLLINS CFO 224333 14148 45805 284286 MICHAEL TITUS VP CLINICAL SERVICES 178075 12541 47628 238244 DIANE HOLLINGSWORTH PRESIDENT & CEO 264097 17139 51441 332677 BRET HOPMAN VP MARKETING & COMM. 153446 11023 40709 205178 CATHERINE MCCLORY DIR. COMPLIANCE & QC 146074 9541 22090 177705 INDU VADAKKEPATTATH DATA SCI. & APP MGR. 142932 9413 22113 174458 ONKAR SAWANT DIR. RESEARCH 158673 10214 21251 190138 CAITLIN LOPES DIR. PARTN. RELATION 111233 7902 38421 157556 FORM 990 - ORGANIZATION'S MISSION EVERSIGHT'S MISSION IS TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. BLINDING EYE DISEASES AFFECT 80 MILLION AMERICANS. THAT MEANS MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, DRIVE TO WORK OR READ THE NEWSPAPER ON A SUNDAY MORNING. THEIR VISION LOSS RESULTS IN AN ECONOMIC IMPACT OF 51.4 BILLION EVERY YEAR IN THE UNITED STATES ALONE. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL MOTHERS CAN SEE THEIR CHILDREN AND ALL CHILDREN CAN GROW UP TO LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. TO MAKE VISION A REALITY FOR ALL, EVERSIGHT CONTINUOUSLY WORKS TO EXPAND ITS REACH, CONNECT MORE EFFECTIVELY WITH COMMUNITIES IN NEED AND PROVIDE THE GIFT OF SIGHT TO EVERYONE. FORM 990, PAGE 1, PART I, LINE 6 VOLUNTEERS PROVIDE VARIOUS TYPES OF SERVICES, INCLUDING LEADERSHIP, THROUGH OUR BOARD OF DIRECTORS (NATIONAL), AND OUR SERVICE AREA ADVISORY BOARDS. WE ALSO WORK WITH MEMBERS OF THE LIONS CLUB IN MICHIGAN AND THROUGHOUT OUR SERVICE AREAS TO SHARE INFORMATION ABOUT EVERSIGHT AND EYE DONATION, AND TO GATHER INTEL AND FACILITATE MEANINGFUL CONNECTIONS IN THE LOCAL COMMUNITIES WE SERVE. VOLUNTEERS HELP PLAN EVENTS SUCH AS OUR ILLINOIS GIFT OF SIGHT CHARITY EVENT, AND OUR MICHIGAN-BASED GIFT OF SIGHT GOLF CLASSIC, AND SERVE AS REPRESENTATIVES AT DONOR FAMILY GATHERINGS AND OTHER EVENTS. FORM 990, PAGE 2, PART III, LINE 4A RESORING SIGHT EVERSIGHT CONTINUES TO TAKE MEANINGFUL STEPS TOWARD TRANSFORMING THE FUTURE OF VISION CARE BY SUPPORTING SUSTAINABLE EYE BANKING INFRASTRUCTURE AND PROVIDING PRICELESS CLINICAL EDUCATION. IN 2023, EVERSIGHT PROVIDED THE GIFT OF SIGHT TO MORE THAN 9,200 PEOPLE ACROSS THE UNITED STATES AND AROUND THE WORLD. EVERSIGHT PROVIDED 42 CORNEAS FOR SIGHT-RESTORING TRANSPLANTS GRATIS OR AT A REDUCED FEE FOR UNINSURED PATIENTS. EVERSIGHT'S WORK BEGAN IN 1947 WITH THE ESTABLISHMENT OF THE FOURTH EYE BANK IN THE UNITED STATES, THEN KNOWN AS THE ILLINOIS EYE-BANK. OVER TIME, NONPROFIT EYE BANKS WERE ESTABLISHED IN EVERY STATE TO MEET THE CRITICAL DEMAND FOR CORNEAL TISSUE TO TREAT PREVENTABLE BLINDNESS. IN 1985, THE ILLINOIS EYE-BANK AND MICHIGAN EYE-BANK FORMED A PARTNERSHIP ONE THAT WOULD EARN A REPUTATION FOR CLINICAL EXCELLENCE MADE POSSIBLE BY SOME OF THE FINEST MEDICAL DIRECTORS, STAFF AND BOARD MEMBERS IN THE EYE BANKING FIELD. THE SUCCESS OF THE ORGANIZATION ATTRACTED AFFILIATIONS WITH OTHER REGIONAL EYE BANKS FORMING ONE OF THE LARGEST NETWORKS OF EYE BANKS IN THE U.S. IN 2015, THE NETWORK BECAME KNOWN AS EVERSIGHT, ALL WORKING TOGETHER AS A UNIFIED OPERATION TO DELIVER THE HIGHEST QUALITY SERVICES TO SURGEONS AND THEIR PATIENTS AND TO CONTINUE TO GROW OUR IMPACT AROUND THE WORLD. EVERSIGHT PROVIDED MORE THAN 13,800 TISSUES FOR TRANSPLANTATION, RESEARCH AND EDUCATION GLOBALLY IN 2023. WE WORKED OR PLACED TISSUE WITH PHYSICIANS AND RESEARCHERS IN 33 COUNTRIES AND FACILITATED TRAINING FOR 865 CLINICIANS. TOGETHER WITH ALL OUR PARTNERS-ADVOCATES, DONOR FAMILIES, TRANSPLANT RECIPIENTS, SURGEONS, LIONS, FELLOW EYE BANKS, HEALTHCARE LEADERS, PHILANTHROPIC SUPPORTERS AND MANY OTHERS-WE WERE ABLE TO MAKE VISION A REALITY FOR MORE PEOPLE WORLDWIDE. FORM 990, PAGE 2, PART III, LINE 4B FINDING A CURE IN THE PURSUIT OF ELIMINATING BLINDING EYE DISEASES, EVERSIGHT ESTABLISHED THE EVERSIGHT CENTER FOR VISION AND EYE BANKING RESEARCH IN CLEVELAND, OHIO, TO PROVIDE LEADING OPHTHALMOLOGY RESEARCHERS WITH THE RESOURCES THEY NEED TO FIND CURES AND TREATMENTS FOR EYE DISEASES SUCH AS AGE-RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY AND GLAUCOMA. EVERSIGHT PROVIDED MORE THAN 4,500 TISSUES FOR RESEARCH AND EDUCATION PURPOSES IN 2023. OUR IN-HOUSE RESEARCH TEAM ALSO PROVIDED EVERSIGHT PARTNERS WITH VALUABLE RESEARCH AND DEVELOPMENT SERVICES, AND PIONEERED NEW EYE BANKING PRACTICES. SINCE 2014, THE EVERSIGHT RESEARCHERS HAVE AUTHORED 47 PUBLICATIONS AND GIVEN 15+ PRESENTATIONS AT INTERNATIONAL CONFERENCES, AND SUPPORTED 230+ PUBLICATIONS OF OUR COLLABORATORS. THE TEAM PUBLISHED EIGHT PEER-REVIEWED PAPERS IN 2023, COVERING TOPICS INCLUDING: BIOLOGIC THERAPEUTICS AND REGENERATIVE MEDICINE; CORNEAL EPITHELIAL HEALING AND STEM CELLS; WET LAB METHODS FOR DMEK SURGICAL TRAINING; RETINAL HISTOLOGY IN RARE GENETIC DISEASE; LITERATURE REVIEW OF CHILDHOOD VISION LOSS; IMPACT OF COVID-19 ON EYE BANKING; DSAEK CELL LOSS IN PRELOADED DEVICES; AND MORE. WITH OUR MANY ACADEMIC PARTNERS, EVERSIGHT RESEARCHERS HAVE CONTRIBUTED TO A TOTAL OF 316 PEER-REVIEWED SCIENTIFIC PAPERS THAT HAVE GARNERED 6,000 CITATIONS AND COUNTING. EVERSIGHT HAS A LONGSTANDING TRACK RECORD OF RESEARCH AND DEVELOPMENT, HAVING AWARDING MORE THAN 4 MILLION IN GRANTS TO DATE THAT STIMULATE PIONEERING CLINICAL AND BASIC SCIENCE RESEARCH AIMING TO DEVELOP NEW WAYS TO RESTORE SIGHT, PREVENT BLINDNESS AND ULTIMATELY HELP PATIENTS LIVE LIFE TO THE FULLEST. SINCE 1980, OUR EYE & VISION RESEARCH GRANT PROGRAM HAS SUPPORTED RESEARCHERS AT LEADING ACADEMIC MEDICAL INSTITUTIONS INCLUDING HARVARD, TUFTS, CLEVELAND CLINIC, CASE WESTERN RESERVE, UNIVERSITY OF MICHIGAN, NORTHWESTERN AND MORE. BY DESIGN, EVERSIGHT'S GRANT PROGRAM PROVIDES CRITICAL, EARLY-STAGE FUNDING THAT IS INTENDED TO DRIVE FOUNDATIONAL RESEARCH AND DISCOVERY. MANY OF THESE PROJECTS HAVE STIMULATED LARGER-SCALE STUDIES AND WON FURTHER FINANCIAL SUPPORT FROM THE NATIONAL INSTITUTES OF HEALTH. IN THE 2024 FUNDING CYCLE, EVERSIGHT AWARDED FOUR GRANTS AT TUFTS UNIVERSITY, WAYNE STATE UNIVERSITY AND UNIVERSITY OF MICHIGAN TO ADVANCE STUDIES TO INVESTIGATE THE EFFICIENCY OF LOCAL ADOPTIVE TRANSFER OF PLASMACYTOID DENDRITIC CELLS (PDCS) IN IMPROVING CORNEA GRAFT SURVIVAL IN HIGH-RISK TRANSPLANTATION; DUAL-ACTING NANOFORMULATIONS FOR THE TREATMENT OF OCULAR BACTERIAL INFECTIONS; PATHOETIOLOGY OF EXTRACELLULAR RETINAL DEPOSITS THAT CAUSE IRREVERSIBLE BLINDNESS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION (AMD) BY DEFINING THE MECHANISM AND COMPOSITION OF RETINAL PIGMENT EPITHELIAL (RPE) LIPOPROTEIN SECRETION; AND OPTIMAL VECTORS AND METHODS FOR DELIVERING GENE BASE EDITING REAGENTS TO TREAT CORNEAL DYSTROPHIES CAUSED BY TGFBI GENE MUTATIONS. EACH YEAR, RECIPIENTS ARE SELECTED BY AN INDEPENDENT REVIEW PANEL OF ACADEMIC RESEARCHERS AND OPHTHALMOLOGISTS. THIS DISTINGUISHED PANEL AWARDS PROPOSALS THAT ENCOURAGE MEANINGFUL SCIENTIFIC INQUISITION AND ALIGN WITH EVERSIGHT'S MISSION TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. FORM 990, PAGE 2, PART III, LINE 4C SUSTAINABLE INTERNATIONAL IMPACT EVERSIGHT WORKS TO ELIMINATE CORNEAL BLINDNESS WORLDWIDE THROUGH EYE BANK DEVELOPMENT, CLINICAL TRAINING AND TISSUE PROVISION. WITH MORE THAN 75 YEARS OF EYE BANKING EXPERTISE, WE DELIVER BOTH SHORT- AND LONG-TERM SOLUTIONS TO TRANSFORM THE LIVES OF MORE THAN 12 MILLION PEOPLE SUFFERING FROM CORNEAL BLINDNESS GLOBALLY. IN 2023, EVERSIGHT INTERNATIONAL PROVIDED MORE THAN 3,800 TISSUES FOR TRANSPLANT AND WORKED WITH SURGEONS IN 32 COUNTRIES OUTSIDE THE UNITED STATES, MAKING THE GIFT OF SIGHT POSSIBLE FOR MANY IN NEED. EVERSIGHT PROVIDED 99 CORNEA TISSUES FOR SIGHT-RESTORING TRANSPLANTS GRATIS OR AT A REDUCED RATE FOR MEDICAL MISSIONS AND UNINSURED PATIENTS OUTSIDE THE UNITED STATES. IN MEDICALLY UNDERSERVED AREAS, EVERSIGHT GLOBAL DEVELOPMENT FOSTERS AUTHENTIC RELATIONSHIPS WITH LOCAL LEADERS TO ESTABLISH CULTURALLY INFORMED EYE DONATION FRAMEWORKS AND SUSTAINABLE EYE BANKING INFRASTRUCTURE. OUR EXPERIENCED TEAM OFFERS VITAL CLINICAL TRAINING AND EDUCATION TO EYE SURGEONS AND EYE BANK TECHNICIANS ON THE LATEST CLINICAL METHODS, IMPROVING ACCESS TO LIFE-CHANGING TRANSPLANTS. THROUGH THE INCREDIBLE GENEROSITY OF OUR DONORS AND DONOR FAMILIES, EVERSIGHT GLOBAL DEVELOPMENT ALSO PROVIDES CORNEAL TISSUE FROM THE UNITED STATES FOR TRANSPLANT AND RESEARCH GLOBALLY, PROVIDING HOPE FOR THE FUTURE AND RESTORING SIGHT TO PATIENTS IN NEED. OUR GLOBAL MISSION IS INFORMED BY AND ALIGNS WITH THE UNITED NATIONS SUSTAINABLE DEVELOPMENT GOALS (SDGS), WITH PARTICULAR ATTENTION GIVEN TO: 3 GOOD HEALTH AND WELL-BEING, 4 QUALITY EDUCATION, 8 DECENT WORK AND ECONOMIC GROWTH, 10 REDUCED INEQUALITIES AND 11 SUSTAINABLE CITIES & COMMUNITIES. ACCORDING TO THE WORLD HEALTH ORGANIZATION, EVERY DOLLAR SPENT ON IMPROVING EYE HEALTH IN UNDERDEVELOPED AREAS GENERATES A FOUR-FOLD RETURN ON INVESTMENT. TO ADDRESS SYSTEMIC UNMET NEED, EVERSIGHT ACTIVELY WORKS WITH MEDICAL PROFESSIONALS, GOVERNMENTS, VISION HEALTH ORGANIZATIONS AND OTHER NGOS IN REGIONS LACKING EYE BANKS AND INFRASTRUCTURE, INCLUDING UNITED ARAB EMIRATES, PAKISTAN AND SOUTH KOREA. WITH PROVEN EYE BANKING AND TECHNICAL TRAINING PRACTICES-AND HAVING PLAYED A PART IN THE ELIMINATION OF THE U.S. CORNEA TRANSPLANT WAITING LIST-EVERSIGHT IS UNIQUELY QUALIFIED TO WORK WITH COUNTRIES LACKING TRANSPLANT PROGRAMS TO HELP THEM ESTABLISH NATIONAL NETWORKS FOR EYE BANKING AND CORNEA DONATION WITH CULTURALLY APPROPRIATE DONATION MODELS AND STATE-OF-THE-ART CLINICAL CAPABILITIES. GLOBALLY, AN ESTIMATED 2.2 BILLION PEOPLE ARE IMPACTED BY BLINDNESS AND VISUAL IMPAIRMENT. NINETY PERCENT OF VISION-IMPAIRED PEOPLE LIVE IN LOW- AND MIDDLE- INCOME COUNTRIES. APPROXIMATELY ONE BILLION OF THESE INDIVIDUALS ARE COPING WITH BLINDNESS OR VISUAL IMPAIRMENT THAT CAN BE CHARACTERIZED AS PREVENTABLE OR NOT SUFFICIENTLY ADDRESSED. VISION LOSS RESULTS IN SUBSTANTIAL ECONOMIC IMPACT WORLDWIDE DUE TO THE INABILITY OF PEOPLE WHO ARE VISION IMPAIRED TO CONTRIBUTE TO THEIR FULLEST IN THEIR COMMUNITIES. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL PEOPLE IN EVERY COMMUNITY CAN LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. WHILE PROVIDING FOR IMMEDIATE GLOBAL CORNEA TRANSPLANT NEEDS WITH U.S. DONOR TISSUE, EVERSIGHT CONTINUES TO ADDRESS THE GLOBAL BURDEN BY EMPOWERING INTERNATIONAL COMMUNITIES TO TAKE MEANINGFUL, SUSTAINABLE STEPS EVERY DAY TO MAKE VISION A REALITY FOR ALL. FORM 990, PAGE 6, PART VI, LINE 11B THE 990 IS REVIEWED BY THE CEO AND CFO PRIOR TO FILING. COMPLETED 990 IS PROVIDED VIA E-MAIL TO ALL BOARD MEMBERS FOR COMMENTS AND QUESTIONS PRIOR TO FILING. FORM 990, PAGE 6, PART VI, LINE 12C THE POLICY IS REVIEWED DURING NEW EMPLOYEE ORIENTATION AND ANNUALLY WITH THE ENTIRE STAFF AND BOARD OF DIRECTORS. ANY POTENTIAL CONFLICTS OF INTEREST ARE REVIEWED BY SENIOR STAFF UPON DISCOVERY. FORM 990, PAGE 6, PART VI, LINE 15A A PERFORMANCE REVIEW IS CONDUCTED BY THE BOARD HR COMMITTEE WITH CEO; MERIT INCREASE IS RECOMMENDED BY THE HR COMMITTEE AND APPROVED BY THE BOARD. THE CEO IS NOT PART OF COMPENSATION DISCUSSION AND CEO DOES NOT PARTICIPATE IN THE SELECTION OF BOARD MEMBERS. THE CEO SALARY IS COMPARED TO SALARIES OF OTHER CEO'S AT PEER ORGANIZATIONS; OTHER EYE BANKS, OPOS, OTHER NONPROFIT ORGANIZATIONS OF SIMILAR SIZE. IN 2016 THE ORGANIZATION ENGAGED THE SERVICES OF AN INDEPENDENT CONSULTANT TO CONDUCT A LEADERSHIP COMPENSATION ANALYSIS. THEIR SOURCE OF SALARY INFORMATION IS THE 990'S ISSUED BY PEER ORGANIZATIONS, MICHIGAN NONPROFIT ASSOCIATION SALARY SURVEY, PUBLISHED BUDGETS, WEB-BASED RESEARCH THROUGH FOIA SOURCES AND INDEPENDENT SALARY SURVEY DATA. FORM 990, PAGE 6, PART VI, LINE 15B PERFORMANCE REVIEW FOR OFFICERS AND KEY EMPLOYEES IS CONDUCTED BY THE EMPLOYEES' IMMEDIATE MANAGER; MERIT INCREASES ARE RECOMMENDED BY THE MANAGER AND APPROVED BY THE CEO. SALARIES OF OFFICERS AND KEY EMPLOYEES ARE COMPARED TO SALARIES OF OTHER SIMILAR POSITIONS AT PEER ORGANIZATIONS; OTHER EYE BANKS, OPOS, OTHER NONPROFIT ORGANIZATIONS OF SIMILAR SIZE. A REPORT IS PROVIDED TO THE HR COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. IN 2016 THE ORGANIZATION ENGAGED THE SERVICES OF AN INDEPENDENT CONSULTANT TO CONDUCT A LEADERSHIP COMPENSATION ANALYSIS. THEIR SOURCE OF SALARY INFORMATION IS THE 990'S ISSUED BY PEER ORGANIZATIONS, MICHIGAN NONPROFIT ASSOCIATION SALARY SURVEY, PUBLISHED BUDGETS, WEB-BASED RESEARCH THROUGH FOIA SOURCES AND INDEPENDENT SALARY SURVEY DATA. FORM 990, PAGE 6, PART VI, LINE 19 GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9 SPECIAL EVENTS EXPENSES -112,950 EVERSIGHT INTERNATIONAL 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108 471671769 EYE BANK MI 3 10 EVERSIGHT EVERSIGHT true EVERSIGHT NEW JERSEY 77 BRANT AVE SUITE 100 CLARK NJ 07066 203345087 EYE BANK NJ 3 7 EVERSIGHT EVERSIGHT true EVERSIGHT MICHIGAN 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108 273107692 EYE BANK MI 3 7 EVERSIGHT EVERSIGHT true EVERSIGHT ILLINOIS 547 WEST JACKSON BLVD SUITE 600 CHICAGO IL 60661 273107617 EYE BANK IL 3 7 EVERSIGHT EVERSIGHT true MIDWIRE SYSTEMS 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108 383557111 SOFTWARE MI 3 10 EVERSIGHT EVERSIGHT true EVERSIGHT OHIO 6700 EUCLID AVE SUITE 101 CLEVELAND OH 44103 455111431 EYE BANK OH 3 7 EVERSIGHT EVERSIGHT true EVERSIGHT CONNECTICUT 3985 RESEARCH PARK DRIVE ANN ARBOR MI 48108 475113503 EYE BANK CT 3 7 EVERSIGHT EVERSIGHT true EVERSIGHT KOREA LLC 145 A 1638 TEHRAN-RO GUMCHEONGU SEOUL GUMCHEON-GU SEOUL KS EYE BANK KS EVER INT EVERSIGHT INTERNATIONAL C CORP false false false false false false false false false false false false true false false true false false false false EVERSIGHT INTERNATIONAL 274622 O 500261 COST EVERSIGHT INTERNATIONAL 231250 L 1757700 COST